My research life, in a nutshell
/Read about my path to MIT and the overarching goals of the group in this MIT News article.
Honored to be a part of this group
/https://news.mit.edu/2022/tenured-engineers-1024
Catherine Henry is named as a 2023 Siebel Scholar!
/The Siebel Scholars Foundation announced the recipients of the 2023 Siebel Scholars award. Our very own Catherine Henry is a worthy recipient!
Now in its 22nd year, the Siebel Scholars program annually recognizes nearly 100 exceptional students commitment to academics and influencing future society. http://ow.ly/jC2f50KQAmM
Congratulations to Catherine and her talented scholar cohort!
It's not a good-bye but a see you later for Huarui
/The lab celebrated the end of Huarui’s tenure at MIT with a late summer lunch at Shy Bird in Kendall Square (not a cloud in the sky). She’ll be joining Maddy Henley at Foghorn Therapeutics, just down the road, to fight the good fight against diseases with aberrant chromatin regulation. Good luck!
New manuscript in Science - drug delivery, screening, cell biology, and machine learning combined to understand how different cancer cells respond to various nanoparticle formulations
/Our collaborative work with the Hammond Lab and the Broad Institute around NanoPRISM was recently published in Science and covered in MIT News:
https://news.mit.edu/2022/how-different-cancer-cells-respond-drug-delivering-nanoparticles-0721
Congratulations to Leyna Duong!
/It is with great pleasure to announce that Leyna Duong is a recipient of the 2022 Department of Chemistry Research Award for outstanding achievement in undergraduate research. We know you’ll tackle grad school with ease!
Congratulations to Dr. Rob Wilson!
/The lab is very proud to announce the successful defense of Rob Wilson, the master of RNA binding proteins. Rob made strong contributions to our strategies to perturb MYC-driven transcription, including work focused on altering MYC transcripts using a variety of strategies (e.g. targeting MAX, LIN28B). He also pioneered a strategy to survey the target tractability of RNA-binding domains, generating new chemical matter for modulating previously intractable targets and staring down and understudied set of targets. Rob is scholar of high standards and his thoughtful criticism will be missed when he heads off to the real world.
Congrats to Morgan on her new Koch Institute Ludwig Center Postdoctoral Fellowship!
/Morgan Stilgenbauer is the recipient of a 2022 Koch Institute Postdoctoral Fellowship, supported by the Ludwig Center at MIT. The fellowship supports her research into novel strategies to modulate the stability of oncogenic transcription factors by directly targeting proteins that regulate stability, such as chaperones or E# ligases, with lead-like or low molecular weight small molecules. Congrats from the team!